Elderly patients are referred with increasing frequency for aortic valve replacement (AVR), due to the ageing of the population and to improved results of surgery. We retrospectively analysed the in-hospital and short-term (up to three years) results of AVR in 185 patients aged G75 years, operated on at our institution from January 2000 to December 2003. Follow-up was completed by a telephone interview during January 2005. Hospital mortality was 6.5% (12 patients). A non-elective operation (Ps0.001), preoperative NYHA functional class GIII (Ps0.06), and chronic renal failure (Ps0.02) were associated with increased operative mortality. Of note, age G80 years did not increase the surgical risk. The 4-year actuarial survival was 70.5%, the event-free survival was 60.6%, and almost all of the interviewed patients thought that they had benefited from the operation. Preoperative intubation, a NYHA class GIII, and a non-elective operation were univariate predictors of a poorer outcome. Our data show that aortic valve replacement may be performed with low morbidity and mortality in the elderly patient (age G75 years), and that an age G80 years neither increases the surgical risk, nor significantly worsens the short-term outcome.
Background
According to the projections of the US National Bureau of the Census, the US population will include 25 million octogenarians by the year 2050, with up to 40% of them experiencing serious cardiovascular symptoms w1x, and a similar scenario will probably occur in Europe. Calcific aortic stenosis is typically observed in the elderly patient, and with the ageing of the population, octogenarian patients are increasingly been scheduled for aortic valve replacement w2x. The aim of this retrospective study is to analyse the in-hospital and short-term results of AVR (isolated or concomitant with other surgical procedures), in patients aged G75 years, with special emphasis on patients aged G80 years.
Methods

Data collection
We retrospectively reviewed the clinical records, outpatient records and surgical reports of all patients aged G75 years undergoing aortic valve replacement (isolated or concomitant with other surgical procedures) at our institution from January 2000 to December 2003. Consid-*Corresponding author. Tel.: q39-0585493604; fax: q39-0585493614. E-mail address: Cerillo@ifc.cnr.it (A.G. Cerillo). ered baseline characteristics included age, gender, body surface area, New York Heart Association functional class, history of angina, congestive heart failure, previous syncope, atrial fibrillation, diabetes, renal failure, smoking history, chronic obstructive pulmonary disease, previous cardiac surgery, previous myocardial infarction, coexistent coronary artery disease, mitral valve disease, and left ventricular ejection fraction. Intraoperative variables included cardiopulmonary bypass time, aortic cross-clamp time, size and brand of the implanted prosthesis, associated surgical procedures, and surgical priority. The surgical priority was defined according to the current indications of the Italian Society for Cardiac Surgery, as can be found on the internet at http:yywww.sicch.ityfilesyFileyDataset_ SICCH_v1.00.pdf. The operation was defined as urgent when the patient underwent surgery within seven days from the diagnosis, and could not be discharged home before the operation. An emergency operation was defined as an operation carried out on referral before the beginning of the next working day. Operative complications and causes of death were recorded and analysed according to previously published guidelines w3x.
Follow-up was completed by a telephone interview during January 2005. Patients were asked to answer a standard questionnaire regarding life style, symptoms, degree of independence, and pharmacological therapy. 
Patient management
All patients underwent coronary angiography prior to the operation. When indicated, myocardial revascularisation was performed concomitant with AVR. A standard cardiopulmonary bypass technique during moderate hypothermia was employed in all cases, with intermittent retrograde warm blood cardioplegia for myocardial preservation.
Statistical analysis
Normally distributed continuous variables are expressed as mean"S.D. and analysed by the Student's t-test. Dichotomous variables are expressed as percentages, and analysed by the Pearson chi-square test or, when indicated, by the Fisher's exact test. The survival was analysed according to the Kaplan-Meier method. A log-rank test was used to analyse the impact of preoperative and operative variables on the outcome at follow-up.
Results
One hundred and eighty-five patients aged G75 years underwent AVR (isolated or concomitant with other surgical procedures) at our institution between 1 January, 2000 and 31 December, 2003. The mean age was 78.2"2.8, and 50 patients (27.0%) were aged G80 years at operation. Sixty patients (32.4%) underwent concomitant AVR and CABG, and 20 (10.8%) underwent multiple valvular procedures. All except 36 (19.4%) patients were in NYHA class GIII. The baseline and operative features of the study patients are reported in Table 1 .
Operative mortality
Hospital mortality was 6.5% (12 patients). Operative complications and causes of death are reported in Table 2 . A non-elective operation (Ps0.001), preoperative NYHA functional class GIII (Ps0.06), and chronic renal failure (Ps0.02) were associated with increased operative mortality. Of note, age G80 years neither significantly increased the surgical risk (Ps0.8), nor was associated with prolonged intubation (41.5"141.7 vs. 28.7"69.7 h, Ps0.56), prolonged intensive care unit length of stay (62.7"114.4 vs. 55.8"90.5 h, Ps0.79), or with prolonged postoperative stay (12.1"7.4 vs. 10.1"5.2 days, Ps0.17).
As already observed, the hospital mortality tended to be higher in patients with a preoperative NYHA functional class GIII. In this group, the intubation time was significantly longer (28.7"33.4 vs. 6.5"12.7 h, Ps0.04), as tended to be the intensive care unit length of stay (63.8"73.5 vs. 22.3"13.4 h, Ps0.07) , and the postoperative stay (13.2"5.2 vs. 8.1"3.2 days, Ps0.1).
Follow-up
Two patients were lost at follow-up (98.9% complete). Of the remaining 171 patients, 26 died during follow-up, and 13 underwent repeated procedures or had complications requiring hospitalisation ( Table 3 ). The total follow-up was 6715 patients-month. Mean follow-up was 36.3 months (range 13-60 months). At follow-up, one hundred and twenty-seven patients were in NYHA class I or II (Fig. 1) . The 4-year actuarial survival was 70.5%, the event-free survival was 60.6%, and almost all (97.5%) of the interviewed patients thought that they had benefited from the operation. Age G80 years at operation did not influence the short-term survival (Fig. 2) . On the other hand, an NYHA class GIII (Hazard Ratios1.4; 95% CI 1.1-1.8; Ps0.02), preoperative intubation (Hazard Ratios2.9; 95% CI 1.05-6.4; Ps0.03) and a non-elective operation (Hazard Ratios2.6; 95% CI 1.2-4.1; Ps0.001) were univariate predictors of a poorer outcome, and a preoperative an NYHA class GIII was associated with shorter survival at multivariate analysis, although this result was not statistically POD, Post operative day; AVR, aortic valve replacement; MVR, mitral valve replacement; CRF, chronic renal failure; LOS, low output syndrome; GI, gastointestinal; AS, Aortic stenosis; CAD, coronary artery disease; CABG, coronary artery bypass grafting; OTI, preoperative oro-tracheal intubation; RF, respiratory failure; MOF, multi-organ failure; DIC, disseminated intravascular coagulation; CVA, cerebro-vascular accident; COPD, chronic obstructive pulmonary disease; POMI, peri-operative myocardial infarctionyischaemia; ARF, acute renal failure; STEMI, ST-segment elevation myocardial infarction. § Patient operated on a nonelective basis. * Patient 7 initially underwent AVR with a 19-mm stented valve. The operation was uneventful and weaning from bypass was easy. After sternal closure sudden haemodynamic deterioration occurred. The patient was reopened, and the valve was re-explorated. A clot occluding the left main coronary artery ostium was found. After retrograde reperfusion, the prosthesis was removed and a stentless valve implanted. The patient was extubated on POD 8 but never recovered completely. She was transferred to another hospital were she died on POD 41. ** Patient 9 was admitted to the cath lab with ECG signs of acute myocardial infarction and operated on a non-elective basis. significant (Ps0.07) (Fig. 3) . A similar figure was observed when considering the event-free survival (Figs. 4 and 5) .
Discussion
Our data show that aortic valve replacement may be performed with low morbidity and mortality in the elderly patient (age G75 years), and that an age G80 years per se neither increases the surgical risk, nor significantly worsens the short-term outcome. Furthermore, according to our experience, the single most important factor predicting a bad in-hospital and short-term result is an advanced symptomatic status at operation (preoperative NYHA class GIII, preoperative intubation, non-elective operation). As a consequence, the paucisymptomatic octogenarian undergoing aortic valve replacement should be considered as a low-risk patient, and should be expected to experience an uneventful and expedite postoperative recovery.
Advanced age has been repeatedly reported to increase the operative risk in cardiac surgical patients w2, 4, 5x. However, previous research has shown that excellent results may be achieved in selected octogenarians w2, 6, 7x. In their analysis of 436 consecutive cardiac surgical patients aged G75 years, Maharajh and co-workers w6x found that a non-elective operation, the presence of cardiomegaly, and the presence of end-stage organ failure were independent predictors of in-hospital death. In this series, an age G80 years was not associated with a worst outcome. Fruitman and co-workers w7x reported a 7.9% hospital mortality in a group of 127 octogenarian patients undergoing heart operations. Interestingly, in their series there were no hospital deaths in patients undergoing aortic valve replace- ment with or without associated CABG, and the only factors associated with increased hospital mortality were preoperative renal failure and a non-elective operation. Furthermore, at follow-up the SF-36 scores w7-9x in the operated patients were equal to or better than those for the general population aged G65 years, 83.7% of the patients were living at home (versus 46.5% at presurgical admission), and 82.5% of the patients would undergo operation again in retrospect. All these data are similar to our findings, and strengthen the two main facts emerging from our study, that are: (a) in the absence of severe comorbidities, octogenarian patients can undergo aortic valve replacement with low morbidity and mortality, experiencing a quick and uneventful postoperative recovery; and (b) a non-elective operation, a preoperative NYHA class GIII or preoperative intubation, and end-stage organ failure (in particular chronic renal failure) significantly increase the risks of surgery. Some traditional risk factors for patients undergoing AVR did not appear to increase the surgical risk in our series. In particular, a previous cardiac operation and associated surgical procedures did not increase the hospital mortality. A possible explanation for this is the small number of redo patients and of patients undergoing multiple valve procedures in our series: a larger number of combined and redo procedures would probably result in an increase of the observed mortality. Another factor that should be mentioned is prosthesis-patient mismatch (PPM). Although we did not perform an echocardiographic follow-up, most of the 29 patients receiving a 19-mm prosthesis had PPM, defined as an EOAI of -0.85 cm ym , at hospital discharge. However, all patients receiving a 19-mm valve in this series were female with a small (1.64"0.15 m ) BSA, and the use 2 of a 19-mm valve was not associated with increased early mortality. Similar results have previously been reported in the literature by others w10x. A final comment should be made about the possible usefulness of the EuroSCORE system for preoperative risk stratification in elderly patients undergoing AVR. As one can see, the additive EuroSCORE in our series was high (Table 1) , and the operative risk was possibly overestimated by this mean. Indeed, the advanced age has a tremendous impact on the additive EuroSCORE: to give a figure, according According to the AHA-ACC guidelines for aortic valve replacement, in patients with aortic stenosis the only class I indication is represented by the presence of symptoms w11x. In asymptomatic patients, the presence of left ventricular dysfunction and an abnormal response to exercise are considered class IIa indications. In our opinion, some considerations are needed. Elderly patients may not be able to undergo a stress test in the presence of comorbidities (obesity, claudicatio, arthritis, COPD). Furthermore, elderly patients are prone to deny symptoms, and may fail to recognise them w12-14x. Finally, our and other data support the concept that the presence of a frankly symptomatic status is associated with unsatisfactory operative and short-term results. All these facts should be considered before addressing a paucisymptomatic elderly patient with severe AS to medical therapy, and all the efforts should be made to prevent the appearance of left ventricular dysfunction or severe symptoms in these patients.
Several efforts have been recently made to identify early predictors of progression to the symptomatic status in patients with severe AS. Hering and co-workers w13x found that the presence of atypical symptoms (fatigue, dizziness, exertional intolerance, palpitations) and of ECG changes indicative of left ventricular hypertrophy or ST segmenty T-wave abnormalities, are associated with a faster reduction of the aortic valve area (AVA) and shorten the time interval until otherwise asymptomatic patients exhibit classical symptoms of advanced AS. Rosenhek and associates w12x found that the presence of severe calcification of the aortic valve, and a fast reduction of the AVA at echocardiography are associated with a significantly shorter eventfree survival. Finally, several authors have recently shown that increased levels of BNP at the diagnosis are associated with a significantly shorter survival w15x and symptom-free survival w14x. We, therefore, believe that the currently available guidelines should be updated in light of these evidences, and that all the cited strategies should be employed in asymptomatic elderly patients with severe AS in order to better define the appropriateness of surgery and to avoid any late, high-risk operation.
Study limitation
The main limitation of the present study resides in its retrospective design. Furthermore, our analysis was conducted on a limited number of patients, followed for a short period of time. We were able to record a limited number of events, and this weakened the significance of our statistical analysis.
A second major limitation of our work is due to the fact that we do not have data concerning patients' referral: most asymptomatic octogenarians with aortic valve disease are probably not referred for cardiac surgical evaluation by their physicians, and this would result in selection bias.
This notwithstanding, we believe that our data represent a realistic picture of the current AVR patient population in western countries, with regard to both the risk profile and the surgical results, and that our and other recent studies will help in ameliorating the selection criteria for AVR surgery in the elderly patient.
Conclusion
Aortic valve replacement may be performed with excellent results in patients aged G75 years, and age G80 years did not significantly increase the surgical risk in our series. According to our experience, the results of aortic valve surgery are less satisfactory in heavily symptomatic patients and in patients operated on an urgent or emergency basis. We believe that earlier referral should be considered in the elderly patient with AS, and that all the available knowledge should be used to optimise the patient's selection for surgery.
